Overall, the interactions between the gut microbiota and inflammation are highly complex; they often involve gut bacteria-driven immune activation, systemic low-grade inflammation leading to adipose inflammation, and the resultant adipose tissue dysfunction that perpetuates further systemic inflammation, insulin resistance, and (ultimately) obesity (Figure 1). This evidence concerns the gene INS and obesity disorder.